These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15496319)

  • 1. Identification of low-level degradants from low dose tablets.
    Blanchard A; Lee C; Nickerson B; Lohr LL; Jensen AJ; Alsante KM; Sharp TR; Santafianos DP; Morris R; Snyder KD
    J Pharm Biomed Anal; 2004 Oct; 36(2):265-75. PubMed ID: 15496319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural identification and characterization of potential degradants of zotarolimus on zotarolimus-coated drug-eluting stents.
    Chen Q; Zielinski D; Chen J; Nowak S; Zhou CC
    J Pharm Biomed Anal; 2009 Dec; 50(5):778-86. PubMed ID: 19581067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of volatile degradants in formulations containing sesame oil using SPME/GC/MS.
    Chen W; Zhou P; Wong-Moon KC; Cauchon NS
    J Pharm Biomed Anal; 2007 Jun; 44(2):450-5. PubMed ID: 17412547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation, identification and determination of the major degradation product in alprazolam tablets during their stability assay.
    Huidobro AL; Rupérez FJ; Barbas C
    J Pharm Biomed Anal; 2007 Jun; 44(2):404-13. PubMed ID: 17250986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, isolation and characterization of potential degradation product in risperidone tablets.
    Bharathi Ch; Chary DK; Kumar MS; Shankar R; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Jan; 46(1):165-9. PubMed ID: 17981421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
    Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
    J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forced degradation of fentanyl: identification and analysis of impurities and degradants.
    Garg A; Solas DW; Takahashi LH; Cassella JV
    J Pharm Biomed Anal; 2010 Nov; 53(3):325-34. PubMed ID: 20462721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of unknown impurities in simvastatin substance and tablets by liquid chromatography/tandem mass spectrometry.
    Vuletić M; Cindrić M; Koruznjak JD
    J Pharm Biomed Anal; 2005 Apr; 37(4):715-21. PubMed ID: 15797793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparative isolation and high-resolution mass identification of 10 stressed study degradants of nicorandil tablets.
    Prakash L; Malipeddi H; Subbaiah BV
    J Chromatogr Sci; 2015 Jan; 53(1):122-6. PubMed ID: 24837014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and quantitative determination of impurities in piperaquine phosphate by HPLC and LC/MS/MS.
    Dongre VG; Karmuse PP; Ghugare PD; Gupta M; Nerurkar B; Shaha C; Kumar A
    J Pharm Biomed Anal; 2007 Jan; 43(1):186-95. PubMed ID: 16916594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, isolation and characterization of a new degradation product in sultamicillin drug substance.
    Kumar VJ; Gupta PB; Kumar KS; Ray UK; Sreenivasulu B; Kumar GS; Rao KR; Sharma HK; Mukkanti K
    J Pharm Biomed Anal; 2011 Feb; 54(3):582-7. PubMed ID: 20934824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of LC-NMR and LC-MS for the separation and rapid structure elucidation of an unknown impurity in 5-aminosalicylic acid.
    Novak P; Tepes P; Fistrić I; Bratos I; Gabelica V
    J Pharm Biomed Anal; 2006 Mar; 40(5):1268-72. PubMed ID: 16253464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid structure elucidation of drug degradation products using mechanism-based stress studies in conjunction with LC-MS(n) and NMR spectroscopy: identification of a photodegradation product of betamethasone dipropionate.
    Lin M; Li M; Buevich AV; Osterman R; Rustum AM
    J Pharm Biomed Anal; 2009 Oct; 50(3):275-80. PubMed ID: 19525081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of process related impurities in chloroquine and hydroxychloroquine by LC/IT/MS, LC/TOF/MS and NMR.
    Dongre VG; Ghugare PD; Karmuse P; Singh D; Jadhav A; Kumar A
    J Pharm Biomed Anal; 2009 May; 49(4):873-9. PubMed ID: 19201565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of degradation products in stressed tablets of Rabeprazole sodium by HPLC-hyphenated techniques.
    Vasu Dev R; Sai Uday Kiran G; Venkata Subbaiah B; Suresh Babu B; Moses Babu J; Dubey PK; Vyas K
    Magn Reson Chem; 2009 May; 47(5):443-8. PubMed ID: 19173350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between liquid chromatography-UV detection and liquid chromatography-mass spectrometry for the characterization of impurities and/or degradants present in trimethoprim tablets.
    Barbarin N; Henion JD; Wu Y
    J Chromatogr A; 2002 Sep; 970(1-2):141-54. PubMed ID: 12350089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of low level degradants in aztreonam injection and an innovative approach to aid HPLC method validation.
    Ye Q; Ding W; Rinaldi F; Huang Y; Miller SA; Bolgar M
    J Pharm Biomed Anal; 2016 May; 124():358-364. PubMed ID: 26991056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of liquid chromatography-two-dimensional nuclear magnetic resonance spectroscopy using pre-concentration column trapping and liquid chromatography-mass spectrometry for the identification of degradation products in stressed commercial amlodipine maleate tablets.
    Murakami T; Fukutsu N; Kondo J; Kawasaki T; Kusu F
    J Chromatogr A; 2008 Feb; 1181(1-2):67-76. PubMed ID: 18191867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation and identification of a degradant in chlorproguanil-dapsone-artesunate (Dacart™) tablets.
    Bardsley B; Barry SJ; Drozdz MA; Hancock SA; Okafo GN; Szafran MM
    J Pharm Biomed Anal; 2011 Feb; 54(3):610-3. PubMed ID: 20970278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.